← Eichor
Study identifier: NCT07726953 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Full-Course ECMO Strategy for Moderate-to-Severe ARDS

Condition: Acute Respiratory Distress Syndrome  ·  Sponsor: Southeast University, China

PhaseNA
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

China faces major challenges in the ECMO management of patients with moderate-to-severe ARDS, including substantial heterogeneity in clinical practice, low weaning success rates, and high complication rates. A key underlying reason is the lack of a standardized full-course management pathway that is applicable to real-world clinical practice in China. This study focuses on the construction and evidence-based evaluation of a precision full-course ECMO management pathway for patients with moderate-to-severe ARDS, aiming to address fragmented care processes and delayed quality improvement. The study includes three main components. First, multidisciplinary consensus and evidence-based findings will be integrated to develop a standardized management pathway covering the full chain of assessment, initiation, maintenance, weaning, and rehabilitation. Second, a nationwide multicenter real-world study with a before-and-after design will be conducted to systematically evaluate the clinical effectiveness of this pathway in reducing mortality and complications and improving patient outcomes. Third, a closed-loop dynamic optimization system based on "pathway-data-feedback-improvement" will be established. With the support of an intelligent data platform and multidisciplinary review mechanisms, the pathway will be continuously updated and refined. Through this study, a reproducible, traceable, and evaluable full-course ECMO management strategy is expected to be established. The study wil…

This description comes directly from the study's public registry record.

Talk to the study team

yingzi Huang, M.D.  ·  18271428804  ·  yz_huang@126.com

Always discuss trial participation with your own doctor first.

Locations (39)

Beijing Anzhen Hospital, Capital Medical UniversityBeijing, ChinaRecruiting
The Second Hospital of Jilin UniversityChangchun, ChinaNot Yet Recruiting
West China Tianfu Hospital, Sichuan UniversityChengdu, ChinaNot Yet Recruiting
The First People's Hospital of ChenzhouChenzhou, ChinaNot Yet Recruiting
The Second Affiliated Hospital of Dalian Medical UniversityDalian, ChinaRecruiting
Fuzhou University Affiliated Provincial HospitalFuzhou, ChinaRecruiting
The First Affiliated Hospital of Guangzhou Medical UniversityGuangzhou, ChinaRecruiting
Affiliated Hangzhou First People's Hospital of Westlake University School of MedicineHangzhou, ChinaNot Yet Recruiting
The Second Affiliated Hospital of Zhejiang University School of MedicineHangzhou, ChinaRecruiting
The First Affiliated Hospital of Harbin Medical UniversityHa’erbin, ChinaNot Yet Recruiting
The Second Affiliated Hospital of Harbin Medical UniversityHa’erbin, ChinaRecruiting
Huai'an First People's HospitalHuai'an, ChinaNot Yet Recruiting

+ 27 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07726953